Development of metronidazole-resistant lines of Blastocystis sp.

Parasitology Research

Volumn 111, Issue 1, 2012, Pages 441-450

  Dunn, L A ^a   Tan, K S W ^b   Vanelle, P ^c   Juspin, T ^c   Crozet, M D ^c   Terme, T ^c   Upcroft, P ^a   Upcroft, J A ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 NITROIMIDAZOLE DERIVATIVE; FURAZOLIDONE; METRONIDAZOLE; NITAZOXANIDE; ORNIDAZOLE; RONIDAZOLE; SATRANIDAZOLE; SECNIDAZOLE; TINIDAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLASTOCYSTIS; CONTROLLED STUDY; DRUG EFFICACY; MORPHOLOGY; NONHUMAN; PARASITE ISOLATION; PRIORITY JOURNAL; SPECIES DIFFERENTIATION;

ANIMALS; ANTIPROTOZOAL AGENTS; BLASTOCYSTIS; DRUG RESISTANCE; METRONIDAZOLE;

BLASTOCYSTIS; BLASTOCYSTIS SP.;

EID: 84862754639     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-012-2860-7     Document Type: Article

References (54)

1. M Amenta ER Dalle Nogare C Colomba TS Prestileo F Di Lorenzo S Fundaro A Colomba A Ferrieri 1999 Intestinal protozoa in HIV-infected patients: effect of rifaximin in Cryptosporidium parvum and Blastocystis hominis infections J Chemother 11 391 395 10632386 1:STN:280:DC%2BD3c%2Fps1antQ%3D%3D
2. KF Boorom H Smith L Nimri E Viscogliosi G Spanakos U Parkar LH Li XN Zhou UZ Ok S Leelayoova MS Jones 2008 Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection Parasit Vectors 1 40 18937874 10.1186/1756-3305-1-40
3. PF Boreham RE Phillips RW Shepherd 1984 The sensitivity of Giardia intestinalis to drugs in vitro J Antimicrob Chemother 14 449 461 6511706 10.1093/jac/14.5.449 1:CAS:528:DyaL2MXitFSqtQ%3D%3D
4. XQ Chen M Singh LC Ho KT Moe SW Tan EH Yap 1997 A survey of Blastocystis sp. in rodents Lab Anim Sci 47 91 94 9051654 1:STN:280:DyaK2s3gsVSrsA%3D%3D
5. XQ Chen M Singh LC Ho SW Tan GC Ng KT Moe EH Yap 1997 Description of a Blastocystis species from Rattus norvegicus Parasitol Res 83 313 318 9134551 10.1007/s004360050255 1:STN:280:DyaK2s3otVWqtw%3D%3D
6. MK Chourasia SK Jain 2003 Pharmaceutical approaches to colon targeted drug delivery systems J Pharm Pharm Sci 6 33 66 12753729 1:CAS:528: DC%2BD3sXivVKru7c%3D
7. S Cimerman MC Ladeira WA Iuliano 2003 Blastocystosis: nitazoxanide as a new therapeutic option Rev Soc Bras Med Trop 36 415 417 12908045 10.1590/S0037-86822003000300016
8. MD Crozet C Botta M Gasquet C Curti V Rémusat S Hutter O Chapelle N Azas M De Méo P Vanelle 2009 Lowering of 5-nitroimidazole's mutagenicity: towards optimal antiparasitic pharmacophore Eur J Med Chem 44 653 659 18590939 10.1016/j.ejmech.2008.05.015 1:CAS:528:DC%2BD1MXitlWjsL4%3D
9. F Denoeud M Roussel B Noel I Wawrzyniak C Da Silva M Diogon E Viscogliosi C Brochier-Armanet A Couloux J Poulain B Segurens V Anthouard C Texier N Blot P Poirier GC Ng KS Tan F Artiguenave O Jaillon JM Aury F Delbac P Wincker CP Vivarès H El Alaoui 2011 Genome sequence of the stramenopile Blastocystis, a human anaerobic parasite Genome Biol 12 R29 21439036 10.1186/gb-2011-12-3-r29 1:CAS:528:DC%2BC3MXkvVersrg%3D
10. E Diaz J Mondragon E Ramirez R Bernal 2003 Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico AmJTrop Med Hyg 68 384 385 1:CAS:528:DC%2BD3sXjslymtro%3D
11. LA Dunn PFL Boreham 1991 The in-vitro activity of drugs against Blastocystis hominis J Antimicrob Chemother 27 507 516 1856129 10.1093/jac/27.4.507 1:CAS:528:DyaK3MXltlWktb0%3D
12. LA Dunn PFL Boreham DJ Stenzel 1989 Ultrastructural variation of Blastocystis hominis stocks in culture Int J Parasitol 19 43 56 2707962 10.1016/0020-7519(89)90020-9 1:STN:280:DyaL1M3htlWmsQ%3D%3D
13. LA Dunn KT Andrews JS McCarthy JM Wright TS Skinner-Adams P Upcroft JA Upcroft 2007 The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis Int J Antimicrob Agents 29 98 102 17137752 10.1016/j.ijantimicag.2006.08.026 1:CAS:528:DC%2BD2sXht1Srtg%3D%3D
14. LA Dunn AG Burgess KG Krauer L Eckmann P Vanelle MD Crozet FD Gillin P Upcroft JA Upcroft 2010 A new generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro Int J Antimicrob Agents 36 37 42 20456926 10.1016/j.ijantimicag.2010.03.004 1:CAS:528:DC%2BC3cXmsVGrsbg%3D
15. MJ Farthing 2006 Treatment options for the eradication of intestinal protozoa Nat Clin Pract Gastroenterol Hepatol 3 436 445 16883348 10.1038/ncpgasthep0557 1:CAS:528:DC%2BD28Xos1GktL8%3D
16. A Giacometti O Cirioni L Antonicelli G D'Amato C Silvestri MS Del Prete G Scalise 2003 Prevalence of intestinal parasites among individuals with allergic skin diseases J Parasitol 89 490 492 12880246 10.1645/0022-3395(2003)089[0490: POIPAI]2.0.CO;2
17. DM Hameed OM Hassanin NM Zuel-Fakkar 2011 Association of Blastocystis hominis genetic subtypes with urticaria Parasitol Res 108 553 560 20922413 10.1007/s00436-010-2097-2
18. K Haresh K Suresh A Khairul Anuar S Saminathan 1999 Isolate resistance of Blastocystis hominis to metronidazole Trop Med Int Health 4 274 277 10357863 10.1046/j.1365-3156.1999.00398.x 1:CAS:528:DyaK1MXjsF2nsr0%3D
19. EM Hussein AM Hussein MM Eida MM Atwa 2008 Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats Parasitol Res 102 853 860 18193282 10.1007/s00436-007-0833-z
20. S Johnson SR Homann KM Bettin JN Quick CR Clabots LR Peterson DN Gerding 1992 Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial Ann Intern Med 117 297 302 1322075 1:STN:280:DyaK38zksVWmtA%3D%3D
21. T Juspin L Zink MD Crozet T Terme P Vanelle 2011 High functionalization of 5-nitro-1H-imidazole derivatives: the TDAE approach Molecules 16 6883 6993 21841727 10.3390/molecules16086883 1:CAS:528:DC%2BC3MXhtFCku7rJ
22. EJ Kather SL Marks PH Kass 2007 Determination of the in vitro susceptibility of feline Tritrichomonas foetus to 5 antimicrobial agents J Vet Intern Med 21 966 970 17939550 10.1111/j.1939-1676.2007.tb03050.x
23. S Kumar K Tamura IB Jakobsen M Nei 2001 MEGA2: molecular evolutionary genetics analysis software Bioinformatics 17 1244 1245 11751241 10.1093/bioinformatics/17.12.1244 1:CAS:528:DC%2BD38XmtVCktQ%3D%3D
24. Y Lantsman KSW Tan M Morada N Yarlett 2008 Biochemical characterization of a mithchondrial-like organelle from Blastocystis sp. subtype 7 Microbiology 154 2757 2766 18757809 10.1099/mic.0.2008/017897-0 1:CAS:528:DC%2BD1cXhtF2gtbrP
25. D Leitsch AG Burgess LA Dunn KG Krauer K Tan M Duchêne P Upcroft L Eckmann JA Upcroft 2011 Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia J Antimicrob Chemother 66 1756 1765 21602576 10.1093/jac/dkr192 1:CAS:528:DC%2BC3MXptFCmtb0%3D
26. DN LeVine MG Papich JL Gookin GS Davidson JL Davis RB Hayes 2011 Ronidazole pharmacokinetics after intravenous and oral immediate-release capsule administration in healthy cats J Feline Med Surg 13 244 250 21239199 10.1016/j.jfms.2010.12.001
27. H Mirza JD Teo J Upcroft KS Tan 2011 A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities Antimicrob Agents Chemother 55 637 648 21098237 10.1128/AAC.00900-10 1:CAS:528: DC%2BC3MXisVyjsbo%3D
28. DD Moghaddam E Ghadirian M Azami 2005 Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole Parasitol Res 96 273 275 15915364 10.1007/s00436-005-1363-1
29. AM Nasirudeen YE Hian M Singh KS Tan 2004 Metronidazole induces programmed cell death in the protozoan parasite Blastocystis hominis Microbiology 150 33 43 14702395 10.1099/mic.0.26496-0 1:CAS:528: DC%2BD2cXosVWnug%3D%3D
30. L Nigro L Larocca L Massarelli I Patamia S Minniti F Palermo B Cacopardo 2003 A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole J Travel Med 10 128 130 12650658 10.2310/7060.2003.31714
31. UZ Ok N Girginkardeşler C Balcioǧlu P Ertan T Pirildar AA Kilimcioǧlu 1999 Effect of trimethoprim-sulfamethaxazole in Blastocystis hominis infection Am J Gastroenterol 94 3245 3247 10566723 10.1111/j.1572-0241. 1999.01529.x 1:CAS:528:DyaK1MXnvFSjtr8%3D
32. U Parkar RJ Traub S Kumar M Mungthin S Vitali S Leelayoova K Morris RC Thompson 2007 Direct characterization of Blastocystis from faeces by PCR and evidence of zoonotic potential Parasitology 134 359 367 17052374 10.1017/S0031182006001582 1:CAS:528:DC%2BD2sXhtFGltbs%3D
33. U Parkar RJ Traub S Vitali A Elliot B Levecke I Robertson T Geurden J Steele B Drake RC Thompson 2010 Molecular characterization of Blastocystis isolates from zoo animals and their animal-keepers Vet Parasitol 169 8 17 20089360 10.1016/j.vetpar.2009.12.032 1:CAS:528:DC%2BC3cXjs1ejt70%3D
34. JF Rossignol SM Kabil M Said H Samir AM Younis 2005 Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis Clin Gastroenterol Hepatol 3 987 991 16234044 10.1016/S1542-3565(05) 00427-1 1:CAS:528:DC%2BD2MXhtFyltLbL
35. JD Silberman ML Sogin DD Leipe CG Clark 1996 Human parasite finds taxonomic home Nature 380 398 8602239 10.1038/380398a0 1:CAS:528: DyaK28XitVKqt74%3D
36. L Souppart G Sanciu A Cian I Wawrzyniak F Delbac M Capron E Dei-Cas K Boorom L Delhaes E Viscogliosi 2009 Molecular epidemiology of human Blastocystis isolates in France Parasitol Res 105 413 421 19290540 10.1007/s00436-009-1398-9
37. D Stark S van Hal D Marriott J Ellis J Harkness 2007 Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis Int J Parasitol 37 11 20 17070814 10.1016/j.ijpara.2006.09.009 1:CAS:528:DC%2BD2sXht1ajsA%3D%3D
38. CR Stensvold GK Suresh KS Tan RC Thompson RJ Traub E Viscogliosi H Yoshikawa CG Clark 2007 Terminology for Blastocystis subtypes-a consensus Trends Parasitol 23 93 96 17241816 10.1016/j.pt.2007.01.004
39. CR Stensvold HC Lewis AM Hammerum LJ Porsbo SS Nielsen KE Olsen MC Arendrup HV Nielsen K Mølbak 2009 Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite Epidemiol Infect 137 1655 1663 19393117 10.1017/S0950268809002672 1:STN:280:DC%2BD1MnisleltA%3D%3D
40. CR Stensvold HV Smith R Nagel KE Olsen RJ Traub 2010 Eradication of Blastocystis carriage with antimicrobials: reality or delusion? J Clin Gastroenterol 44 85 90 19834337 10.1097/MCG.0b013e3181bb86ba
41. KS Tan 2008 New insights on classification, identification, and clinical relevance of Blastocystis spp Clin Microbiol Rev 21 639 665 18854485 10.1128/CMR.00022-08 1:CAS:528:DC%2BD1cXhtlClurfI
42. KS Tan H Mirza JD Teo B Wu PA Macary 2010 Current views on the clinical relevance of Blastocystis spp Curr Infect Dis Rep 12 28 35 21308496 10.1007/s11908-009-0073-8
43. JA Upcroft P Upcroft 2001 Drug susceptibility testing of anaerobic protozoa Antimicrob Agents Chemother 45 1810 1814 11353630 10.1128/AAC.45.6. 1810-1814.2001 1:CAS:528:DC%2BD3MXjslyqsb8%3D
44. P Upcroft JA Upcroft 2001 Drug targets and mechanisms of resistance in the anaerobic protozoa Clin Microbiol Rev 14 150 164 11148007 10.1128/CMR.14.1.150-164.2001 1:CAS:528:DC%2BD3MXnvFantg%3D%3D
45. JA Upcroft LA Dunn JM Wright 2006 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis Antimicrob Agents Chemother 50 344 347 16377707 10.1128/AAC.50.1.344-347.2006 1:CAS:528:DC%2BD28XivVGqtQ%3D%3D
46. CA Valdez JC Tripp Y Miyamoto J Kalisiak P Hruz YS Andersen SE Brown K Kangas LV Arzu BJ Davids FD Gillin JA Upcroft P Upcroft VV Fokin DK Smith KB Sharpless L Eckmann 2009 Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia J Med Chem 52 4038 4053 19480409 10.1021/jm900356n 1:CAS:528:DC%2BD1MXmsFams70%3D
47. AA Vdovenko JE Williams 2000 Blastocystis hominis: neutral red supravital staining and its application to in vitro drug sensitivity testing Parasitol Res 86 573 581 10935909 10.1007/PL00008533 1:STN:280:DC%2BD3M%2FlslaktA%3D%3D
48. C Vogelberg CR Stensvold S Monecke A Ditzen K Stopsack U Heinrich-Gräfe C Pöhlmann 2010 Blastocystis sp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms Parasitol Int 59 469 471 20363362 10.1016/j.parint.2010.03.009
49. KH Wong GC Ng RT Lin H Yoshikawa MB Taylor KS Tan 2008 Predominance of subtype 3 among Blastocystis isolates from a major hospital in Singapore Parasitol Res 102 663 670 18064490 10.1007/s00436-007-0808-0
50. J Yakoob W Jafri N Jafri M Islam M Asim Beg 2004 In vitro susceptibility of Blastocystis hominis isolated from patients with irritable bowel syndrome Br J Biomed Sci 61 75 77 15250669 1:CAS:528:DC%2BD2cXmvVWqur4%3D
51. J Yakoob W Jafri N Jafri R Khan M Islam MA Beg V Zaman 2004 Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis AmJTrop Med Hyg 70 383 385
52. J Yakoob W Jafri MA Beg Z Abbas S Naz M Islam R Khan 2010 Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria Parasitol Res 107 679 684 20532564 10.1007/s00436-010-1918-7
53. J Yakoob W Jafri MA Beg Z Abbas S Naz M Islam R Khan 2010 Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis Parasitol Res 106 1033 1038 20177906 10.1007/s00436-010-1761-x
54. E Zimre-Grabensteiner N Arshad A Amin M Hess 2011 Genetically different clonal isolates of Trichomonas gallinae, obtained from the same bird, can vary in their drug susceptibility, an in vitro evidence Parasitol Int 60 213 215 21345378 10.1016/j.parint.2011.02.003 1:CAS:528:DC%2BC3MXksFSqs7g%3D